About Cervel
Cervel is a company based in Redwood City (United States) founded in 2008 was acquired by Rio Grande Neurosciences in October 2015. Cervel has raised $23.6 million across 6 funding rounds from investors including East West Bank, D. E. Shaw Group and Rio Grande Neurosciences. Cervel operates in a competitive market with competitors including Freespira, Motif neurotech, Sooma Oy, Neuronetics and Magnus Medical, among others.
- Headquarter Redwood City, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23.6 M (USD)
in 6 rounds
-
Latest Funding Round
$1 M (USD), Series C
Nov 26, 2014
-
Investors
East West Bank
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Rio Grande Neurosciences
(Oct 20, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cervel
Cervel has successfully raised a total of $23.6M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $1 million completed in November 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $1.0M
-
First Round
First Round
(30 Nov 2009)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2014 | Amount | Series C - Cervel | Valuation |
investors |
|
| Apr, 2013 | Amount | Debt – Conventional - Cervel | Valuation |
investors |
|
| Apr, 2013 | Amount | Series C - Cervel | Valuation | D. E. Shaw Group , Aberdare Ventures |
|
Investors in Cervel
Cervel has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include East West Bank, D. E. Shaw Group and Rio Grande Neurosciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US Life-Sciences sectors are targeted for investment by Aberdare Ventures.
|
Founded Year | Domain | Location | |
|
Commercial banking services are offered to individuals and businesses.
|
Founded Year | Domain | Location | |
|
Multinational investment management services are provided globally.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cervel
Financial Statements - Cervel
Cervel Comparisons
Competitors of Cervel
Cervel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Freespira, Motif neurotech, Sooma Oy, Neuronetics and Magnus Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Panic disorders are treated via breathing device and mobile app.
|
|
| domain | founded_year | HQ Location |
Minimally invasive bioelectronics are developed for mental health disorders.
|
|
| domain | founded_year | HQ Location |
Non-invasive neuromodulation therapies
|
|
| domain | founded_year | HQ Location |
Non-invasive magnetic therapies for psychiatric and neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive neuromodulation systems for depression treatment are provided.
|
|
| domain | founded_year | HQ Location |
Neurostimulation devices for opioid withdrawal symptoms are developed.
|
Frequently Asked Questions about Cervel
Cervel was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Cervel is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Cervel is a funded company, having raised a total of $23.6M across 6 funding rounds to date.
Cervel Neurotech was founded in 2008 as a privately held medical device company based in Redwood City, United States. Focus is placed on non-invasive deep brain neuromodulation for treatment-resistant depression within the healthcare sector. Repetitive transcranial magnetic stimulation (rTMS) is utilized, where magnetic fields are applied to induce electrical currents in targeted brain areas, thereby modulating neural function. Operations center on device development and clinical applications for psychiatric conditions.
Cervel's top competitors include NeuroSigma, Magnus Medical and Motif neurotech.
Cervel has 4 investors. Key investors include East West Bank, D. E. Shaw Group, Rio Grande Neurosciences, and Aberdare Ventures.